Showing results (31-40 of 7,369) with videos related to
Sort By:
Pageof 737
Lancet (London, England)|September 18, 2022
The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysisRobert Luo, Youyi Fong, Debi Boeras, et al.Statistics in Medicine|June 10, 2025
Negative Control Outcome Adjustment in Early-Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected InfantsEthan Ashby, Bo Zhang, Genevieve G Fouda, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|December 28, 2020
Immunobridging efficacy of a tetravalent dengue vaccine against dengue and against hospitalized dengue from children/adolescents to adults in highly endemic countriesYing Huang, Zoe Moodie, Michal Juraska, et al.The Journal of Infectious Diseases|December 2, 2017
Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin AmericaZoe Moodie, Michal Juraska, Ying Huang, et al.Biostatistics (Oxford, England)|December 24, 2014
Kernel-based logistic regression model for protein sequence without vectorializationYouyi Fong, Saheli Datta, Ivelin S Georgiev, et al.Journal of the Royal Society, Interface|March 28, 2014
Herpes simplex virus-2 transmission probability estimates based on quantity of viral sheddingJoshua T Schiffer, Bryan T Mayer, Youyi Fong, et al.Open Forum Infectious Diseases|January 19, 2023
Antibody Correlates of Protection From Severe Respiratory Syncytial Virus Disease in a Vaccine Efficacy TrialYouyi Fong, Ying Huang, Bhavesh Borate, et al.Journal of Biopharmaceutical Statistics|June 12, 2014
Nonlinear Calibration Model Choice between the Four and Five-Parameter Logistic ModelsWilliam N Cumberland, Youyi Fong, Xuesong Yu, et al.BMC Infectious Diseases|February 22, 2018
Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trialYouyi Fong, M Elizabeth Halloran, Jin Kyung Park, et al.Plos One|June 17, 2020
Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin AmericaLindsay N Carpp, Youyi Fong, Matthew Bonaparte, et al.Pageof 737